Beta-Lactamase Inhibitor Compositions, Methods of Use, and Methods of Treatment

These beta-lactamase inhibitors can be used to target multi-drug resistant organisms including MRSA. Further, these compounds may help to overcome microbial resistance to betalactam antibiotics by restoring the efficacy of the beta-lactam compounds that the microbe is resistant to. These inhibitors could be used to restore the activity of penicillin, cephalosporin and carbapenem against multi-drug resistant strains of bacteria. Therefore, it is appropriate to suggest that these novel compositions may be used to develop new antibiotic treatment regimens.

US 9,556,131 issued 2017-01-31   [MORE INFO]

Type of Offer: Licensing

Next Patent »
« More Chemistry Patents
« More Pharmaceutical Patents

Share on      

CrowdSell Your Patent